York Space Systems Reports Second Quarter 2026 Results
Key Terms
adjusted ebitda financial
idiq regulatory
task orders regulatory
Significant Backlog Potential Growth on Eight Contract Wins at
($ in thousands, except percentages) |
For the three months ended June 30, |
|||||||||
|
|
2026 |
|
|
|
2025 |
|
|
% Change |
|
Revenue |
$ |
92,547 |
|
|
$ |
83,839 |
|
|
10 |
% |
Gross profit |
|
22,180 |
|
|
|
9,526 |
|
|
133 |
% |
Net loss |
|
(39,343 |
) |
|
|
(24,234 |
) |
|
62 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
(9,503 |
) |
|
$ |
(8,919 |
) |
|
7 |
% |
($ in thousands, except percentages) |
For the six months ended June 30, |
|||||||||
|
|
2026 |
|
|
|
2025 |
|
|
% Change |
|
Revenue |
$ |
208,890 |
|
|
$ |
190,091 |
|
|
10 |
% |
Gross profit |
|
44,330 |
|
|
|
34,128 |
|
|
30 |
% |
Net loss |
|
(154,185 |
) |
|
|
(35,963 |
) |
|
329 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
(13,142 |
) |
|
$ |
(3,465 |
) |
|
279 |
% |
* See definition and reconciliation of Adjusted EBITDA to net loss under “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Measures.”
“York had another strong quarter of execution,” said Dirk Wallinger, CEO of York. “Through the first half of 2026, we’ve secured eight contract wins at an
“Throughout 2026, and increasingly in Q2, we continued to observe a meaningful shift in how the
Under this model, smaller initial awards to proven providers can serve as gateways to multi-billion-dollar operational programs that can be executed more quickly later given the contracts have already been awarded. York has been awarded six contracts under this new approach in 2026 alone, and the company believes they can be significant drivers of growth into 2027 as the follow-on programs advance.
Brian Frantz, interim CFO and CAO of York, said, “Our newer programs are driving strong profitability improvements, and we continue to successfully win a large rate of the contracts available to us as we wait on the government to make progress against the larger programs in the budget. As a result, we are bringing down our full year 2026 revenue guidance. That said, the contracts we’ve secured this year under the new acquisition approach are the onboarding positions that we expect to convert to significantly larger operational programs, and we expect them to be meaningful drivers of growth in 2027 and beyond."
Second quarter 2026 Company Results
Revenue increased
Gross Margin increased 13 percentage points to
Backlog stood at
Selected Second Quarter Highlights
-
Year-to-date, York has secured eight contracts at an approximately
88% win rate across ten different mission areas. - York expanded its national security customer base with four new contract awards in Q2, including three IDIQ vehicles, one of which has already generated two delivery orders.
- In July, York was awarded a Task Order contract on one of our highly selective IDIQs, to deliver military system capabilities built on commercial technologies. And in early August, York was awarded another Task Order for an on-orbit demonstration. This highlights the rapid conversion from IDIQ selection to multiple funded delivery order contracts in a matter of weeks.
- In July, York was selected by USSF for the NITE-STAR IDIQ, further extending York’s mission portfolio capabilities. The award positions York to compete for task orders integrating the company’s satellite platforms with the global ground network operated by ATLAS Space Operations, a wholly owned subsidiary of York.
- York became the first performer to complete its T1TL deliveries, launching a second dedicated Falcon 9 that put 21 York-built satellites on orbit and bringing York’s program record to 42-for-42, ahead of every other awardee.
-
In July, York completed its acquisition of ALL.SPACE, a leader in assured communications terminals, extending York’s reach into adjacent markets and position the company to capture the accelerating demand for unmanned systems across domains. ALL.SPACE brings established contracts with the Army and Navy including a new Defense Innovation Unit contract and a
follow-on order from the Navy, both awarded in Q3.$6M - York’s Nemesis mission cleared its Delta Critical Design Review and remains on track for spacecraft delivery in Q4, extending York’s prime integration model into GEO in support of Space Domain Awareness missions and reinforces the company’s ability to prime, integrate, and deliver across orbital regimes.
-
York completed its acquisition of Solestial, Inc., a leading provider of next-generation space solar technology. The acquisition secures domestic control of a critical element of York’s supply chain, currently controlled by
China , reduces geopolitical exposure across the company’s manufacturing base, and positions York to leverage advanced solar capabilities as a differentiator in future spacecraft designs. - York completed its initial Dragoon mission objectives in a matter of months, demonstrating York’s ability to deliver operationally relevant tactical communications at speed and scale.
Liquidity
As of June 30, 2026, our cash and cash equivalents were
Business outlook as of August 13, 2026
York Space Systems expects revenue for the full year 2026 to be in the range of
We are working on a pipeline of government opportunities worth
Business outlook is based on information as of today, August 13, 2026, and may be impacted by factors outside York’s control. See “Forward Looking Statements.”
Conference Call
York will host a conference call to review its financial results for the fiscal quarter and full year 2025 and its outlook for the future and may disclose other material developments affecting its business and/or financial performance. Listeners may access the conference call live via audio webcast.
Thursday August 13, 2026
3:00 pm Mountain Time (5:00 pm Eastern Time)
Webcast: https://events.q4inc.com/attendee/324017794
York’s financial results release will be available after the close of market on August 13, 2026 on York’s website at http://ir.yorkspacesystems.com. An audio webcast replay of the conference call will be available for one year at http://ir.yorkspacesystems.com.
About York Space Systems
York Space Systems (NYSE: YSS) is a leading,
Forward-Looking Statements
This press release and the related conference call contain “forward-looking statements” within the meaning of, and we intend such forward-looking statements to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. In particular, statements about our 2026 outlook, future growth prospects, anticipated award times, pipeline, award opportunities, backlog, backlog opportunities, growth of market share, growth strategy, capabilities, the future health of our aircraft, expectations regarding government programs and actions, benefits expected from the acquisitions of Solestial Space Technology, Inc. and ALL.SPACE Holdings, Inc., the markets in which we operate, including growth of our various markets, potential new products and product innovation and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance contained in this press release and made during the related conference call, are forward-looking statements.
Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include: disruptions in
Non-GAAP Financial Measures
We believe that in addition to our results determined in accordance with
These non-GAAP financial measures are used to supplement the financial information presented on a GAAP basis and should not be considered in isolation or as a substitute for the relevant GAAP measures and should be read in conjunction with information presented on a GAAP basis. Because not all companies use identical calculations, our presentation of non-GAAP measures may not be comparable to other similarly titled measures of other companies.
Non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact on our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which items are adjusted to calculate our non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in our public disclosures.
Contribution Margin
We refer to revenue less direct material costs of revenue as “contribution margin” and contribution margin divided by revenue as “contribution margin %.” The closest comparable GAAP financial measures to contribution margin and contribution margin % are gross profit and gross profit margin %, respectively. We believe contribution margin and contribution margin % are useful measures of the variable costs that we incur in order to provide services to our customers. Our presentation of contribution margin and contribution margin % should not be construed as an inference that our future results will be unaffected by variable costs.
EBITDA and Adjusted EBITDA
We define EBITDA as net income (loss) adjusted for interest expense, interest income, income tax benefit, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted for changes in the fair value of derivatives, loss on debt extinguishment, transaction costs, and other non-recurring items. Net loss is the most directly comparable GAAP measure to Adjusted EBITDA. Our presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, see the “Reconciliation of GAAP to Non-GAAP Results” table in this press release.
Backlog
We view backlog as a key measure of our business growth. Backlog represents our estimate of the revenue we expect to realize in future periods as a result of performing work on contracts that have been awarded to us (net of any revenue already recognized as of the backlog date). We include the aggregate expected revenue of awarded contracts in our backlog upon the execution of a legally binding agreement, even though our contracts include certain termination rights exercisable by our customers with advance notice. We exclude unexercised contract options from our backlog. Contract liabilities recognized on our consolidated balance sheets consists of payments and billings that we have received in excess of revenue that we have recognized. Because cash receipts from these contracts have not been recognized into revenue, they are included in our backlog calculation.
We monitor our backlog because we believe it is a forward-looking indicator of potential sales which can be helpful to investors in evaluating the performance of our business and identifying trends over time. Although backlog reflects business associated with contracts that are considered to be firm, terminations, amendments, or contract cancellations may occur, which could result in a reduction in our total backlog and potential future revenue that is never recognized.
APPENDIX - 1 |
||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) |
||||||||||||||
|
For the three months ended June 30, |
For the six months ended June 30, |
||||||||||||
($ in thousands, except shares and per share amounts) |
|
2026 |
|
|
|
2025 |
|
|
2026 |
|
|
|
2025 |
|
Revenue |
$ |
92,547 |
|
|
$ |
83,839 |
|
$ |
208,890 |
|
|
$ |
190,091 |
|
Cost of revenues |
|
70,367 |
|
|
|
74,313 |
|
|
164,560 |
|
|
|
155,963 |
|
Gross profit |
|
22,180 |
|
|
|
9,526 |
|
|
44,330 |
|
|
|
34,128 |
|
Operating expenses |
|
|
|
|
|
|
||||||||
Selling, general and administrative expenses |
|
40,825 |
|
|
|
25,790 |
|
|
77,531 |
|
|
|
52,591 |
|
Stock compensation expense |
|
10,893 |
|
|
|
— |
|
|
95,589 |
|
|
|
— |
|
Research and development expenses |
|
5,766 |
|
|
|
4,893 |
|
|
11,055 |
|
|
|
9,294 |
|
Transaction costs |
|
6,009 |
|
|
|
75 |
|
|
11,934 |
|
|
|
106 |
|
Total operating expenses |
|
63,493 |
|
|
|
30,758 |
|
|
196,109 |
|
|
|
61,991 |
|
Loss from operations |
|
(41,313 |
) |
|
|
(21,232 |
) |
|
(151,779 |
) |
|
|
(27,863 |
) |
Other (expense) income |
|
|
|
|
|
|
||||||||
Interest expense |
|
(2,884 |
) |
|
|
(7,118 |
) |
|
(5,783 |
) |
|
|
(14,177 |
) |
Interest income |
|
4,208 |
|
|
|
218 |
|
|
8,828 |
|
|
|
759 |
|
Other income (expense), net |
|
928 |
|
|
|
1,201 |
|
|
(5,279 |
) |
|
|
1,315 |
|
Total other expense |
|
2,252 |
|
|
|
(5,699 |
) |
|
(2,234 |
) |
|
|
(12,103 |
) |
Loss before provision for income taxes |
|
(39,061 |
) |
|
|
(26,931 |
) |
|
(154,013 |
) |
|
|
(39,966 |
) |
Income tax (expense) benefit |
|
(282 |
) |
|
|
2,697 |
|
|
(172 |
) |
|
|
4,003 |
|
Net loss |
$ |
(39,343 |
) |
|
$ |
(24,234 |
) |
$ |
(154,185 |
) |
|
$ |
(35,963 |
) |
Foreign currency translation adjustment |
|
49 |
|
|
|
372 |
|
|
(72 |
) |
|
|
857 |
|
Comprehensive loss |
$ |
(39,294 |
) |
|
$ |
(23,862 |
) |
$ |
(154,257 |
) |
|
$ |
(35,106 |
) |
Net loss per common share |
|
|
|
|
|
|
||||||||
Net loss |
$ |
(39,343 |
) |
|
$ |
(24,234 |
) |
$ |
(154,185 |
) |
|
$ |
(35,963 |
) |
Less: Accretion of Class P Units |
$ |
— |
|
|
$ |
— |
|
$ |
192 |
|
|
$ |
— |
|
Less: Deemed dividend on Conversion of the Class P Units upon IPO |
$ |
— |
|
|
$ |
— |
|
$ |
60,722 |
|
|
$ |
— |
|
Net loss available to common shareholders |
$ |
(39,343 |
) |
|
$ |
(24,234 |
) |
$ |
(215,099 |
) |
|
$ |
(35,963 |
) |
Basic and diluted net loss per share |
$ |
(0.31 |
) |
|
$ |
(0.25 |
) |
$ |
(1.76 |
) |
|
$ |
(0.38 |
) |
Weighted average common shares outstanding |
|
|
|
|
|
|
||||||||
Basic and diluted weighted common shares outstanding |
|
128,095,949 |
|
|
|
95,141,928 |
|
|
122,092,664 |
|
|
|
95,141,928 |
|
Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
($ in thousands) |
|
As of June 30, 2026 |
|
As of December 31, 2025 |
||||
Assets |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
534,000 |
|
|
$ |
162,573 |
|
Accounts receivable, net |
|
|
55,800 |
|
|
|
11,539 |
|
Inventories |
|
|
41,787 |
|
|
|
18,747 |
|
Prepaid expenses and other current assets |
|
|
20,988 |
|
|
|
31,478 |
|
Contract assets |
|
|
114,967 |
|
|
|
76,809 |
|
Capitalized commissions, net |
|
|
4,305 |
|
|
|
6,661 |
|
Total current assets |
|
|
771,847 |
|
|
|
307,807 |
|
Fixed assets, net |
|
|
58,070 |
|
|
|
46,293 |
|
Right of use assets, net |
|
|
28,445 |
|
|
|
24,683 |
|
Goodwill |
|
|
793,520 |
|
|
|
674,262 |
|
Other intangibles, net |
|
|
412,828 |
|
|
|
407,925 |
|
Other assets |
|
|
5,509 |
|
|
|
14,415 |
|
Total assets |
|
$ |
2,070,219 |
|
|
$ |
1,475,385 |
|
Liabilities, Temporary Equity and Member's Capital/Stockholders' Equity |
|
|
|
|
||||
Current liabilities |
|
|
|
|
||||
Contract liabilities |
|
$ |
18,157 |
|
|
$ |
110,275 |
|
Accounts payable and accrued expenses |
|
|
110,015 |
|
|
|
68,358 |
|
Operating lease liabilities, current |
|
|
3,942 |
|
|
|
3,260 |
|
Income taxes payable |
|
|
831 |
|
|
|
672 |
|
Long-term debt, current |
|
|
5,625 |
|
|
|
3,750 |
|
Deferred commissions, current |
|
|
5,266 |
|
|
|
5,038 |
|
Other current liabilities |
|
|
835 |
|
|
|
— |
|
Total current liabilities |
|
|
144,671 |
|
|
|
191,353 |
|
Operating lease liabilities, less current portion |
|
|
26,330 |
|
|
|
23,161 |
|
Deferred commissions, less current portion |
|
|
1,191 |
|
|
|
2,110 |
|
Long-term debt, net |
|
|
141,419 |
|
|
|
144,962 |
|
Derivative liability associated with Class P Units |
|
|
— |
|
|
|
93,411 |
|
Other liabilities |
|
|
4,717 |
|
|
|
3,353 |
|
Deferred income tax liability |
|
|
6,084 |
|
|
|
6,096 |
|
Total liabilities |
|
$ |
324,412 |
|
|
$ |
464,446 |
|
Commitments and contingencies |
|
|
|
|
||||
Temporary Equity |
|
|
|
|
||||
Class P Units (240,956,348 and 0 units authorized, issued and outstanding at December 31, 2025 and 2024, respectively; |
|
|
— |
|
|
|
143,115 |
|
Member's Capital/Stockholders Equity |
|
|
|
|
||||
Common units (0 and 50,000,000 authorized, issued and outstanding at June 30, 2026 and December 31, 2025, respectively) |
|
|
— |
|
|
|
1,135,910 |
|
Common stock ( |
|
|
13 |
|
|
|
— |
|
Additional paid-in-capital |
|
|
2,168,137 |
|
|
|
— |
|
Accumulated other comprehensive income (loss) |
|
|
864 |
|
|
|
936 |
|
Accumulated deficit |
|
|
(423,207 |
) |
|
|
(269,022 |
) |
Total member's capital |
|
|
1,745,807 |
|
|
|
867,824 |
|
Total liabilities, temporary equity, and member's capital/stockholders' equity |
|
$ |
2,070,219 |
|
|
$ |
1,475,385 |
|
Condensed Consolidated Statements of Cash Flows (Unaudited) |
||||||||
|
|
For the six months ended June 30, |
||||||
($ in thousands) |
|
|
2026 |
|
|
|
2025 |
|
Cash flows from operating activities |
|
|
|
|
||||
Net loss |
|
|
(154,185 |
) |
|
$ |
(35,963 |
) |
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
30,989 |
|
|
|
24,261 |
|
Stock compensation expense |
|
|
95,589 |
|
|
|
— |
|
Amortization of debt issuance costs |
|
|
418 |
|
|
|
428 |
|
Non-cash lease expense |
|
|
2,110 |
|
|
|
1,297 |
|
Amortization of capitalized commissions |
|
|
2,316 |
|
|
|
3,229 |
|
Deferred taxes |
|
|
(237 |
) |
|
|
(3,998 |
) |
Loss on equity investments, net |
|
|
1,594 |
|
|
|
— |
|
Other, net |
|
|
5,772 |
|
|
|
(894 |
) |
Changes in assets and liabilities, net of the effect of acquisitions: |
|
|
|
|
||||
Accounts receivable, net |
|
|
(43,447 |
) |
|
|
(7,333 |
) |
Inventories |
|
|
(24,042 |
) |
|
|
7,137 |
|
Prepaid expenses and other current assets |
|
|
6,651 |
|
|
|
20,873 |
|
Contract assets |
|
|
(38,159 |
) |
|
|
(42,932 |
) |
Other assets |
|
|
(476 |
) |
|
|
(54 |
) |
Contract liabilities |
|
|
(95,815 |
) |
|
|
(72,852 |
) |
Accounts payable and accrued expenses |
|
|
26,831 |
|
|
|
7,814 |
|
Deferred commissions |
|
|
(691 |
) |
|
|
(1,338 |
) |
Income taxes payable |
|
|
149 |
|
|
|
— |
|
Related party payables |
|
|
— |
|
|
|
1,276 |
|
Other liabilities |
|
|
17 |
|
|
|
436 |
|
Right of use assets and operating lease liabilities, net |
|
|
(2,021 |
) |
|
|
(1,209 |
) |
Net cash (used in) operating activities |
|
|
(186,637 |
) |
|
|
(99,822 |
) |
Cash flows from investing activities |
|
|
|
|
||||
Capital expenditures |
|
|
(3,430 |
) |
|
|
(1,272 |
) |
Equity investments |
|
|
(6,156 |
) |
|
|
(5,000 |
) |
Acquisition of business, net of cash acquired |
|
|
(25,152 |
) |
|
|
— |
|
Issuance of notes receivable |
|
|
— |
|
|
|
(2,500 |
) |
Proceeds from settlement of notes receivable |
|
|
5,000 |
|
|
|
— |
|
Net cash (used in)/provided by investing activities |
|
|
(29,738 |
) |
|
|
(8,772 |
) |
Cash flows from financing activities |
|
|
|
|
||||
Proceeds from issuance of common stock in connection with the IPO, net of underwriting discounts and commissions |
|
|
592,833 |
|
|
|
— |
|
Payment of offering costs in connection with the IPO |
|
|
(3,192 |
) |
|
|
— |
|
Repayment of principal on long-term debt |
|
|
(1,875 |
) |
|
|
— |
|
Proceeds from settlement of notes receivable |
|
|
— |
|
|
|
25,000 |
|
Net cash provided by financing activities |
|
|
587,766 |
|
|
|
25,000 |
|
Net increase/(decrease) in cash and cash equivalents |
|
|
371,391 |
|
|
|
(83,594 |
) |
Effect of exchange rate changes on cash |
|
|
36 |
|
|
|
156 |
|
Cash and cash equivalents, beginning of period |
|
|
162,573 |
|
|
|
104,656 |
|
Cash at end of period |
|
$ |
534,000 |
|
|
$ |
21,218 |
|
Supplemental disclosures of cash flow information |
|
|
|
|
||||
Cash payments for interest |
|
$ |
5,682 |
|
|
$ |
6,090 |
|
Cash (refunded)/paid for taxes |
|
|
(11 |
) |
|
|
3 |
|
Noncash operating, investing, and financing |
|
|
|
|
||||
Changes in accounts payable and accruals for purchases of fixed assets |
|
|
1,483 |
|
|
|
1,346 |
|
Conversion of common units into shares of common stock upon IPO |
|
|
1,135,718 |
|
|
|
— |
|
Conversion of Class P Units into shares of common stock upon IPO |
|
|
241,391 |
|
|
|
— |
|
Issuance of common shares for acquisition of Orbion |
|
|
60,180 |
|
|
|
— |
|
Issuance of common shares for acquisition of Solestial |
|
|
51,857 |
|
|
|
— |
|
APPENDIX - 2 |
||||||||||||||
Reconciliation of GAAP to Non-GAAP Results |
||||||||||||||
Contribution Margin (Unaudited) |
||||||||||||||
|
For the three months ended June 30, |
For the six months ended June 30, |
||||||||||||
($ in thousands, except percentages) |
|
2026 |
|
|
|
2025 |
|
|
2026 |
|
|
|
2025 |
|
Revenue |
$ |
92,547 |
|
|
$ |
83,839 |
|
$ |
208,890 |
|
|
$ |
190,091 |
|
Direct material costs |
|
53,240 |
|
|
|
63,555 |
|
|
129,517 |
|
|
|
134,505 |
|
Contribution margin (non-GAAP) |
$ |
39,307 |
|
|
$ |
20,284 |
|
$ |
79,373 |
|
|
$ |
55,586 |
|
Contribution margin % (non-GAAP) |
|
42 |
% |
|
|
24 |
% |
|
38 |
% |
|
|
29 |
% |
Reconciliation to Contribution Margin (Unaudited) |
||||||||||||||
($ in thousands, except percentages) |
For the three months ended June 30, |
For the six months ended June 30, |
||||||||||||
|
|
2026 |
|
|
|
2025 |
|
|
2026 |
|
|
|
2025 |
|
Revenue |
$ |
92,547 |
|
|
$ |
83,839 |
|
$ |
208,890 |
|
|
$ |
190,091 |
|
Less: Cost of revenues |
|
70,367 |
|
|
|
74,313 |
|
|
164,560 |
|
|
|
155,963 |
|
Gross profit (GAAP) |
$ |
22,180 |
|
|
$ |
9,526 |
|
$ |
44,330 |
|
|
$ |
34,128 |
|
Gross profit % (GAAP) |
|
24 |
% |
|
|
11 |
% |
|
21 |
% |
|
|
18 |
% |
Add: Direct labor costs |
|
11,119 |
|
|
|
7,661 |
|
|
21,275 |
|
|
|
15,385 |
|
Add: Direct overhead costs |
|
3,736 |
|
|
|
1,669 |
|
|
7,079 |
|
|
|
3,384 |
|
Add: Depreciation and amortization |
|
2,272 |
|
|
|
1,428 |
|
|
6,689 |
|
|
|
2,689 |
|
Contribution margin (non-GAAP) |
$ |
39,307 |
|
|
$ |
20,284 |
|
$ |
79,373 |
|
|
$ |
55,586 |
|
Contribution margin % (non-GAAP) |
|
42 |
% |
|
|
24 |
% |
|
38 |
% |
|
|
29 |
% |
Reconciliation of Net Loss to Adjusted EBITDA (Unaudited) |
||||||||||||||
|
For the three months ended June 30, |
For the six months ended June 30, |
||||||||||||
($ in thousands) |
|
2026 |
|
|
|
2025 |
|
|
2026 |
|
|
|
2025 |
|
Net loss |
$ |
(39,343 |
) |
|
$ |
(24,234 |
) |
$ |
(154,185 |
) |
|
$ |
(35,963 |
) |
Interest expense |
|
2,884 |
|
|
|
7,118 |
|
|
5,783 |
|
|
|
14,177 |
|
Interest income |
|
(4,208 |
) |
|
|
(218 |
) |
|
(8,828 |
) |
|
|
(759 |
) |
Income tax expense (benefit) |
|
282 |
|
|
|
(2,697 |
) |
|
172 |
|
|
|
(4,003 |
) |
Depreciation and amortization |
|
14,886 |
|
|
|
12,225 |
|
|
30,989 |
|
|
|
24,261 |
|
EBITDA (non-GAAP) |
$ |
(25,499 |
) |
|
$ |
(7,806 |
) |
$ |
(126,069 |
) |
|
$ |
(2,287 |
) |
Changes in the fair value of derivatives |
|
(1,117 |
) |
|
|
(1,254 |
) |
|
3,713 |
|
|
|
(1,396 |
) |
Stock-based compensation expense |
|
10,893 |
|
|
|
— |
|
|
95,589 |
|
|
|
— |
|
Transaction costs(1) |
|
6,009 |
|
|
|
75 |
|
|
11,934 |
|
|
|
106 |
|
Other(2) |
|
211 |
|
|
|
66 |
|
|
1,691 |
|
|
|
112 |
|
Adjusted EBITDA (non-GAAP) |
$ |
(9,503 |
) |
|
$ |
(8,919 |
) |
$ |
(13,142 |
) |
|
$ |
(3,465 |
) |
(1) |
|
Represents costs for legal, advisory fees and other costs incurred in connection with the Company's acquisition activity and one-time IPO costs. |
|
(2) |
|
Other includes a gain and loss on the initial investments for Solestial and Orbion, respectively, net gain on foreign exchange and one-time non-cash expense. |
Backlog (Unaudited) |
|||||
($ in thousands) |
As of June 30, 2026 |
|
As of December 31, 2025 |
||
Backlog |
$ |
592,049 |
|
$ |
542,557 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260812603626/en/
Investor Contact
Christopher Evenden
ir@yorkspacesystems.com
Media Contact
Sarah Nickell
Sarah.nickell@yorkspacesystems.com
Source: York Space Systems Inc.